Spinal Stenosis Devices Market
Jul 21, 2022
FDA Approval to Centinel’s Total Disc Replacement Devices; FDA clears DyAnsys’ Neurostimulator; Orthox to Commence FFLEX Study; Cordis Started Enrolment for RADIANCY Clinical Study; Orthofix & LimaCorporate Announce Partnership; Medtronic to Partner With AWS
Orthox Obtains MHRA Approval to Commence FFLEX Study On July 14, 2022, Orthodox Ltd, a clinical-stage company created medical implants to treat orthopedic problems including damaged knee articular cartilage. It was founded in 2008 by life scientist, Dr. Nick Skaer, and knee surgeon, Professor Oliver Kessle...
Read More...
Jun 11, 2021
Spinal Stenosis Devices Market Size to Balloon Up Owing to Increasing Prevalence & Geriatric Population, as well as Medical Advancements
Spinal stenosis refers to the condition characterized by the compression of nerve roots and narrowing of the spinal canal due to several pathologic factors, further leading to symptoms such as pain with a tingling sensation, numbness, and weakness. Spinal stenosis can involve the cervical, lumbar, or thoracic (rare...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
